Covered recipient · General Payments record
SUSAN CAFFERY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Pediatrics
General Payments · PY2021–2024
$3,781.93
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,069.21 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $486.07 | 10 |
| Alnylam Pharmaceuticals Inc. | $222.40 | 2 |
| Neurelis, Inc. | $137.07 | 2 |
| Marinus Pharmaceuticals, Inc. | $122.31 | 1 |
| BIOCODEX, INC. | $55.53 | 1 |
| JAZZ PHARMACEUTICALS INC. | $45.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $100.56 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125849760 | CMS |
| Alnylam Pharmaceuticals Inc. | $121.84 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125849860 | CMS |
| BIOCODEX, INC. | $55.53 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146420670 | CMS |
| JAZZ PHARMACEUTICALS INC. | $45.83 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151309066 | CMS |
| Marinus Pharmaceuticals, Inc. | $122.31 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141324780 | CMS |
| Neurelis, Inc. | $105.07 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145661312 | CMS |
| Neurelis, Inc. | $32.00 | 12/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145661314 | CMS |
| UCB, Inc. | $5.84 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143171292 | CMS |
| UCB, Inc. | $6.22 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143171294 | CMS |
| UCB, Inc. | $6.01 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143171296 | CMS |
| UCB, Inc. | $7.43 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143171298 | CMS |
| UCB, Inc. | $6.81 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143171300 | CMS |
| UCB, Inc. | $112.49 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143171302 | CMS |
| UCB, Inc. | $6.26 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143171304 | CMS |
| UCB, Inc. | $98.25 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143171306 | CMS |
| UCB, Inc. | $93.82 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143171308 | CMS |
| UCB, Inc. | $142.94 | 12/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143171310 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.